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RECEPTOR ACTIVITY OF THE EUTOPIC AND ECTOPIC ENDOMETRIUM TO ESTROGEN 
AND PROGESTERONE MARKERS IN CASE OF ADENOMYOSIS AVAILABLE DURING 
POSTMENOPAUSE 
 
Abstract. Objective of the study is to determine ER, PR and AR activity of eutopic and ectopic 
endometrium in case of adenomyosis available during post-menopause. Materials and methods. 30 
cases of adenomyosis have been examined in case of hyperplastic processes in the endometrium and 
without them in patients aged from 51 to 73 years. Immunohistological examination has been 
conducted with the purpose to determine the state of receptor apparatus to ER, PR and AR markers. 
Immunohistological examinations conducted in ectopic foci determined a high mean score of the spread 
of ER staining of the glandular cells in case of endometrioid adenocarcinoma of the uterus (EACU) and 
endometrial hyperplasia (EHP) and the stromal cells in the group with EHP. A high mean index of 
intensity and spread of ER staining of the eutopic endometrium glandular component was found in all 
the groups. Considerable differences between mean indices of intensity and spread of ER staining of the 
glandular and stromal cells in adenomyosis foci both between the groups themselves and the examined 
components are absent (р>0,05). An increased level of PR activity was detected respectively to the 
improvement of differentiation degree of the eutopic endometrium epithelial cells. The comparison of 
the results of PR activity of the stromal cells and glands of the europic and ectopic endometrium did not 
find any deviations between the examined indices (р>0,05). Comparison of the degree of AR expression 
did not find differences between the groups (р>0,05). Conclusions. Adenomyosis during post-menopause 
period is characterized by prevailed expression level of ER glandular component of the eutopic 
endometrium over the endometrium in adenomyosis foci in case of EACU and endometrium atrophy 
available. Increase of ER and PR expression levels occurs respectively to the increase of cellular 
differentiation degree. Considerable differences by the indices of intensity and staining of PR of the 
glandular and stromal cells in adenomyosis foci were not found both between the groups themselves 
and the examined components. Considerable differences by AR expression levels in the eutopic and 
ectopic endometrium were not found as well. Prospects of further studies: to carry out the analysis of 
ER, PR and AR expression levels in the ovaries in case adenomyosis available.   
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Introduction. Endometriosis is benign 
hormone-dependent inflammatory process 
associated with structural-functional changes of 
the female reproductive system, which can be a 
cause of infertility and disorders in the social, 
family and economical spheres of life [3, 15].  176 
million of women in the whole world suffer from 
endometriosis including every 10th one of the 
reproductive age [15, 16]. In 70-80% of all the 
cases endometriosis is manifested by 
adenomyosis [9, 1, 3]. Women of a reproductive 
age are mainly affected [15]. At the same time, the 
disease affects post-menopausal women as well. 
Occurrence of adenomyosis foci during post-
menopausal period is associated with peripheral 
conversion of androstenediol into estrogen or 
against the ground of administration of hormonal 
therapy [15].  
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Still a considerable progress in investigation of 
adenomyosis does not enable to formulate 
completely a clear notion concerning 
etiopathogenesis of the disease. Metabolic 
disorders of estrogens are considered to be a 
leading conception in the development of internal 
endometriosis [7]. In addition to estrogen and 
progesterone receptors the variants of their 
combinations and receptor status of cells are also 
important [3]. The change of balance of these 
hormones followed by the development of 
relative or absolute hyperestrogenemia is the 
main factor provoking adenomyosis. However, 
certain scientists state occurrence of 
endometrioid foci against the ground of 
hypoestrogenemia and restricted hormonal effect 
on the heterotopic tissue [6].  
16-90% of patients who suffer from internal 
endometriosis are known to be diagnosed with 
hyperplastic processes in the endometrium [2]. In 
recent decades many researchers have indicated 
the increase of frequency of comorbid (parallel) 
development of adenomyosis and hyperplastic 
processes in the endometrium [7, 4].  
Investigation of molecular peculiarities of the 
internal endometriosis foci in combination with 
other proliferative diseases of the female 
reproductive system during post-menopausal 
period is a promising approach, since this group is 
not completely studied.   
Objective: to determine receptor activity of 
eutopic and ectopic endometrium to the markers 
of estrogen, progesterone and androgen in case of 
adenomyosis available during post-menopause.   
Materials and methods. The material for the 
study was surgical material (extracted uteri) from 
30 patients (51-73 years of age) with adenomyosis 
in case of comorbid pathology (endometrioid 
adenocarcinoma of the uterus (EACU) and 
endometrial hyperplasia (EHP)) or without it, who 
were treated in the Center of Restoration and 
Reconstructive Medicine (University Clinic) of 
Odessa National Medical University. The selection 
criteria were the following: amenorrhea over 12 
months (post-menopause) and confirmed clinical 
diagnosis of adenomyosis. The patients were 
divided into three groups: the first one included 
10 women with adenomyosis and simple non-
atypical hyperplasia of the endometrium; the 
second group – 10 women with adenomyosis and 
adenocarcinoma of the uterus; the third group 
(control one) – 10 women with adenomyosis and 
age changes.  
The fragments of the material to be examined 
were fixed in 10 % neutral formalin with pH 7.0 
during 24 hours at the temperature of 37 °С. Then 
the specimens were processed according to the 
common unified methods. Immunohistochemical 
reaction was performed with the use of 
monoclonal mouse antibodies of estrogen-
receptor alpha (ER, clone ЕР1), progesterone (РR) 
and androgen antibodies (AR). Expression of 
estrogen, progesterone and androgen markers 
was assessed by the numerical score system of the 
continuous staining method to determine ER- and 
РR-status (Allred D. C. et al., 1998) (Table 1)[14].  
Table 1 
Numerical score system to assess continuous 
staining 
Intensity(І) Spread of staining (П) 
0 = none 
1 = weak 
2 = intermediate 
3 = strong 
(0) – none of stained cells 
(1) – stained cells less than 
1/100 
(2) – number of stained cells 
from 1/100 to 1/10 
(3) – number of stained cells 
from 1/10 to 1/3 
(4) – number of stained cells 
from 1/3 to 2/3 
(5) – number of stained cells 
over 2/3 
General statistical analysis was made by means 
of standard methods of mathematical-statistical 
processing with the use of software MS Office 
Excel. Means values (M) and error of mean values 
(m) were estimated. To compare parametric data 
the method of paired Student criterion was used, 
probability was determined with р<0,05.  
Results. As a result of the immunohisto-
chemical examination conducted on 30 women of 
a post-menopause period suffering from 
adenomyosis with and without hyperplastic 
processes in the endometrium, we have drawn 
the conclusions concerning the levels of receptor 
activity of eutopic and ectopic endometrium to 
the markers of estrogen, progesterone and 
androgen.     
Discussion. Immunohistochemical (IHC) 
examination determined high mean score of the 
spread of ER staining of the glandular cells in the 
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ectopic foci in case of EACU and EHP available, 
3,14±0,6 and 4,14±0,5 respectively (Fig. 1). A 
similar tendency is characteristic for the stroma of 
endometrioid heterotropy in the group with EHP. 
Low indices of ER staining intensity of the stromal 
component of adenomyosis foci were determined 
in case of EACU (0,71±0,31) concerning other 
groups and epithelial cells of ectopic foci in the 
group itself. A lower level of ER expression of the 
glandular component of the endometrioid 
heterotropy was found in case of endometrium 
atrophy than in case of EHP (р<0,05) (Table 2). 
Single scientific works are indicative of prevailed 
receptor activity of the epithelial cells over the 
stromal ones in adenomyosis foci, where the 
groups of the study included mainly women of 
reproductive and pre-menopausal age [11, 13]. 
Examination of ER activity of the glandular 
component of the eutopic endometrium 
presented high mean score of intensity and 
spread of straining in all 3 groups (Fig. 2) (Table 2). 
The results of the study of ER expression of the 
eutopic endometrium are indicative of the 
absence of considerable differences in the levels 
of receptor activity depending on comorbid 
pathology (р>0,05), which agrees partially with 
conclusions of certain scientists. According to the 
evidence of certain sources endometrium in case 
of simple EHP is characterized by a high level of 
estrogen activity with its gradual decrease in case 
of combined EHP and EACU [17]. There is an 
opposite opinion: decreased expression of steroid 
receptors occurs in the direction of the increased 
differentiation of cells, the highest indices are 
found in case of EACU respectively [14, 
17].Assessment of the results of ER activity of the 
eutopic and ectopic endometrium showed that 
the 2nd and 3rd groups of women are characterized 
by higher levels of estrogen expression of the 
epithelial cells in the eutopic endometrium than in 
adenomyosis foci (Fig. 3). Such differences are not 
peculiar for the stromal component (p>0,05). The 
data of certain studies indicate that ER activity is 
lower in endometriod heterotropy than in eutopic 
endometrium [9-11]. However, there are opposite 
opinions concerning prevailing expression of 
steroid hormones in the foci of internal 
endometriosis than in eutopic endometrium [11]. 
Higher estrogen activity of eutopic endometrium 
concerning ectopic one in the group with atrophy 
is explained by insufficient amount of ER 
associated with decrease of their expression in 
endometrioid heterotropy [9, 17].  
Analysis of the activity level of progesterone 






Fig. 1. Adenomyosis focus against the ground of 
simple non-atypical EHP of a 56-year-old woman. 
Estimation for glands – 3+++ in 100%; for stroma – 
2++ in 60%. IHC reaction with antibodies to estrogen. 
х400. 
 
Fig. 2. Simple form of endometrial hyperplasia 
without atypical form in a 73-year-old woman.   
Estimation for glands – 3+++ у 100%; for stroma – 
3+++ у 70%. IHC reaction with antibodies to estrogen. 
х400. 
Table 2 
Mean indices of intensity (І) and spread (П) of staining of ЕR-receptors in eutopic and ectopic 
endometrium (М±m, score) 
Component 
Eutopic endometrium Ectopic endometrium 
Glandular Stromal Glandular Stromal 
Index І П І П І П І П 
І (n=10) 2,67±0,37 4,5±0,55 2,33±0,37 4,17±0,72 2,14±0,37 4,14±0,5 1,86±0,28 3,57±0,46 
ІІ (n=10) 2,56±0,19 4,56±0,26 1,25±0,44 2,63±0,75 1,71±0,31 3,14±0,6 0,71±0,31 2,0±0,85 
ІІІ (n=10) 2,67±0,41 4,67±0,41 1,67±0,41 3,0±0,71 1,11±0,28 1,78±0,58 1,78±0,24 3,11±0,51 
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Fig. 3. Mean indices of intensity and staining of ЕR-receptors in eutopic and ectopic endometrium (М±m, score). 
 
 cells of the glandular and stromal components of 
eutopic endometrium (Fig. 4). Similar to the cases 
with ER expression simple non-atypical EHP is 
characterized by the highest score of intensity– 
«3» and spread of staining of the epithelial cells - 
«5» and their decrease in case of complex atypical 
EHP. The group with EACU is characterized by an 
increased level of receptor PR activity respectively 
to the improvement of EACU differentiation 
degree. The glandular component of low 
differentiated EACU had minimal score in intensity 
and spread of staining, stroma according to the 
given criteria was estimated as “0” in some cases. 
The mentioned indices in the group were the 
highest for high-differentiated EACU. The 
obtained results partially correspond with 
conclusions of other scientists: the highest degree 
of PR activity with simple EHP, and the lowest – 
with complex EHP and EACU [8, 17]. In І and ІІ 
groups stromal component obtained rather high 
score by the level of spread of cellular staining – 
mostly «4» and «5», and as a result mean indices 
are 4,6±0,27 and 4,56±0,36 respectively. Analysis 
of the glandular and stromal components of 
endometrium by the level of intensity and staining 
did not find considerable differences (р>0,05) 
(Table 3), which contradicts the opinion of certain 
scientists concerning the fact that the  number of 
PR is bigger in the stromal cells irrespective of 
endometrial state [8]. Considerable difference 
between mean indices of the degree of intensity 
and spread of staining of glandular and stromal 
cells in the internal endometriosis foci (Fig. 5) was 
not found  between the groups themselves and 
between the examined components (р>0,05) 
(Table3).  
Results of comparison of PR activity of the 
stromal cells and glands of eutopic and ectopic 
endometrium did not find considerable deviations 
between the examined indices (р>0,05) (Fig. 6), 
which contradicts statements of other 
researchers concerning relatively lower level of PR 
expression in adenomyosis foci than in eutopic 
endometrium [7, 11]. There is an opposite opinion 
as well: the components of endometrioid 
 
 
Fig. 4. Endometrioid carcinoma of endometrium G1 in 
a 70-year-old woman. Estimation for glands – 3+++ у 
100%; for stroma – 3+++ in 70%. IHC reaction with 
antibodies to progesterone. х400. 
 
 
Fig. 5. Adenomyosis focus against the ground of 
simple non-atypical EHP in a 60-year-oold woman. 
Estimation for glands – 3+++ у 100%; for stroma – 
3+++ у 70%. IHC reaction with antibodies to 
progesterone. х400. 
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heterotropy have higher PR activity than eutopic 
endometrium [11].  
Analysis of indices of intensity and spread of AR 
staining showed low score – «0» and «1» mainly 
(Fig. 7, 8). Comparison of the degree of AR 
expression did not find considerable differences 
between the groups of patients examined 
(р>0,05) (Fig.9) (Table 4), which corresponds to 
the conclusions of other scientists [7]. However, 
certain scientists draw attention to the available 
differences of internal endometriosis foci by the 
level of receptor expression of steroid hormones, 
and androgenic in particular, from the 
surrounding endometrium [5]. 
Table 3 
Mean indices of intensity (І) and spread (П) of staining of РR-receptors in eutopic and ectopic 
endometrium (М±m, score) 
Component 
Eutopic endometrium Ectopic endometrium 
Glandular Stromal Glandular Stromal 
Index  І П І П І П І П 
І (n=10) 2,4±0,27 4,6±0,27 2,8±0,22 4,2±0,42 2,25±0,55 3,75±1,09 2,0±0,47 4,25±0,55 
ІІ (n=10) 2,56±0,26 4,56±0,36 2,67±0,35 4,0±0,56 2,2±0,65 3,6±1,1 2,0±0,61 3,4±1,04 
ІІІ (n=10) 2,67±0,41 4,33±0,82 2,0±0,71 3,33±0,82 2,25±0,33 4,0±0,49 2,63±0,2 4,38±0,2 
 
 
Fig. 6. Mean indices of intensity and staining of PR-receptors in eutopic and ectopic endometrium (М±m, score). 
 
Table 4 
Mean indices of intensity (І) and spread (П) of staining of АR-receptors in eutopic and ectopic 
endometrium (М±m, score) 
Component 
Eutopic endometrium Ectopic endometrium 
Glandular Stromal Glandular Stromal 
Component  І П І П І П І П 
І (n=10) 0.29±0,2 0,43±0,32 0,57±0,22 0,71±0,31 0,25±0,17 0,25±0,17 0,85±0,13 0,85±0,13 
ІІ (n=10) 1±0 1,33±0,23 1±0 1,17±0,18 0,4±0,27 0,8±0,55 0,8±0,42 0,8±0,42 
ІІІ (n=10) 0,2±0,22 0,2±0,22 0,4±0,27 0,4±0,27 0,5±0,24 0,83±0,52 0,5±0,24 0,5±0,24 
 
Fig. 7. Age changes (endometrial atrophy) in a 68-
year-old woman. Estimation for glands – 1+ in 5%; for 
stroma – 1+ in 0,5%. IHC reaction with antibodies to 
androgen. х400. 
 
Fig. 8. Adenomyosis focus against the ground of 
endometrial atrophy in a 68-year-old woman. 
Estimation for glands – 0 in 100%; for stroma – 0 in 
100%. IHC reaction with antibodies to androgen. 
х400. 




Fig. 9. Mean indices of intensity and staining of АR-receptors in eutopic and ectopic endometrium (М±m, score). 
 
The difference in opinions concerning 
immunohistochemical peculiarities of one and the 
same pathological process can be explained by the 
presence of comorbid pathology of endometrium 
(hyperplastic processes of endometrium) and age 
changes of our patients (post-menopause). 
Prevalent majority of studies associated with 
adenomyosis refer to women of a reproductive 
age and pre-menopausal period without available 
comorbid pathology of endometrium.  
Conclusions. The following immunohisto-
chemical peculiarities were found to be 
characteristic for adenomyosis during post-
menopausal period:   
1. Prevalent level of ER expression of the 
glandular component of eutopic endometrium 
over the endometrium of adenomyosis foci in case 
of EACU available and endometrila atrophy. A low 
level of ER expression in the stromal cells in 
comparison with the glandular ones both in the 
foci of endometrioid heterotropy and eutopic 
endometrium in case of EACU.    
2. Increase of levels of ER and PR expression 
in accordance to the increase of cellular 
differentiation level.   
3. Considerable differences by the indices of 
intensity and staining of PR of the glandular and 
stromal cells in adenomyosis foci between the 
groups and between the examined components 
are not found. 
4. Considerable differences by the levels of 
AR expression in eutopic and ectopic 
endometrium are not found.  
Prospects of further studies: to carry out the 
analysis of ER, PR and AR expression levels in the 
ovaries in case adenomyosis available. 
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